PARI GmbH

What PARI GmbH does

PARI GmbH is a German medical device manufacturer headquartered in Starnberg, Bavaria, that designs, develops, and produces inhalation therapy systems for respiratory and nasopharyngeal diseases. The company's core product portfolio spans the PARI BOY family (Junior for infants, Classic, Pro for COPD, and free portable units), the PARI COMPACT2 tabletop device, and the PARI SINUS2 for pulsating aerosol sinus treatment, all manufactured in-house in Germany under the company's 'Made in Germany' vertical integration model. Underpinning these devices is PARI's proprietary inhalation technology stack, including the LC SPRINT jet nebulizer platform, vibrating membrane technology (PARI BOY free), and the eFlow membrane nebulizer platform that is licensed to pharmaceutical companies for drug-specific inhalation delivery. The portfolio has been independently validated through multiple Stiftung Warentest awards (Testsieger SEHR GUT 1.5 for PARI BOY free; bestes Tischgerät GUT 1.7 for PARI COMPACT2).

PARI operates a dual business model combining B2B2C hardware distribution with B2B technology licensing. Consumer inhalation devices are sold through German pharmacies (Apotheken) and specialist medical dealers, supported by dedicated professional portals for physicians (Ärzteportal) and pharmacies/specialist dealers (Apotheken- und Fachhandelsportal) with associated seminar programs. The eFlow Technology stream represents a parallel licensing business, where PARI develops drug-specific membrane nebulizers for pharmaceutical partners requiring optimized aerosol delivery systems. Target end users include patients across all age cohorts (infants through adults) with conditions such as COPD, asthma, cystic fibrosis, bronchitis, sinusitis, and bronchiolitis, together with the prescribing physicians and dispensing pharmacists who influence device selection.

The company maintains an active multi-channel marketing operation including a disease information website, a blog with expert interviews and patient stories, social media on YouTube, Instagram, LinkedIn, and Facebook, and an interactive product advisor tool. PARI GmbH operates as an independently held private company (GmbH form) with no disclosed parent company, institutional investor, or funding history, and no public revenue or headcount disclosures are available.

Name

PARI GmbH

Legal name

PARI GmbH

Website

https://pari.de

Company type

Private

Operating status

Operating

Short description

PARI GmbH is a German medical device manufacturer that designs, produces, and distributes inhalation therapy devices (PARI BOY, PARI COMPACT2, PARI SINUS2) and licenses its eFlow membrane nebulizer technology to pharmaceutical companies for drug-specific inhalation delivery.

Ownership category

akta.pro rank

Product category

Respiratory Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Nebulizers & Aerosol Drug Delivery Systems (HLAHAIAJ)

Keywords

• Inhalation therapy devices
• Nebulizer systems
• Respiratory medical devices
• Aerosol drug delivery
• Membrane nebulizer technology

Headquarters

HQ city

Starnberg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales (Inhalation Equipment): Sale of inhalation devices including PARI COMPACT2, PARI BOY series (Junior, Classic, Pro, free), and PARI SINUS2. Revenue generated from direct sales to pharmacies and specialist dealers who serve end-patient consumers.
2. OEM/Licensing (eFlow Technology): Licensing of proprietary eFlow membrane technology to pharmaceutical companies for drug-specific nebulizer development and delivery systems

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

PARI GmbH develops, manufactures, and sells medical inhalation devices and nebuliser systems for the treatment of respiratory and nasopharyngeal diseases such as COPD, asthma, cystic fibrosis, bronchitis, sinusitis, and bronchiolitis. Its core product lines include the PARI COMPACT2 tabletop nebulizer, the PARI BOY family (Junior, Classic, Pro, free), and the PARI SINUS2 for sinus treatment. The company also licenses its proprietary eFlow membrane nebulizer platform to pharmaceutical companies for drug-specific inhalation therapies.

Product overview

PARI GmbH offers a portfolio of inhalation therapy devices and pharmaceutical nebulizer technology. The core product line includes tabletop inhalation devices (PARI COMPACT2, PARI BOY series) featuring jet nebulizer technology with LC SPRINT nebulizers, a portable vibrating membrane device (PARI BOY free), and a specialized sinus treatment device (PARI SINUS*2*). The PARI BOY family includes variants for different patient needs: Junior for infants, Classic for general use, and Pro for COPD management. PARI also provides the eFlow Technology platform for pharmaceutical company partnerships, enabling drug-specific membrane nebulizers. Accessories include various masks, mouthpieces, and the PARI PEP S System. All products are manufactured in Germany.

Differentiator

Problem solved

Functional benefit

Products and services

• PARI COMPACT2

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Pharmaceutical Companies (eFlow Technology Partners)coreOEM/ Whitelabel/ Licensing PartnerPARI develops drug-specific membrane nebulizers based on eFlow Technology in partnership with pharmaceutical companies. This represents a core B2B strategic relationship where PARI provides proprietary technology licensing for drug delivery systems.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Aerogen: Aerogen is the leading developer of vibrating-mesh nebulizer technology for acute care and pharma partnerships (e.g., with AstraZeneca). Directly competes with PARI's eFlow platform in drug-device combination development and hospital-grade nebulization.
• Drive DeVilbiss Healthcare: Drive DeVilbiss Healthcare manufactures a broad line of compressor nebulizers and respiratory equipment sold through medical supply dealers. Competes head-to-head with PARI BOY and PARI COMPACT in pharmacy and Fachhandel channels.

Broad incumbents

• Philips Respironics: Philips Respironics is the global incumbent in respiratory care, offering nebulizers, CPAP/BiPAP, ventilators, and oxygen therapy. Directly competes with PARI in hospital and home nebulization while operating at significantly greater scale and geographic breadth.
• CAIRE Inc. CAIRE is a global respiratory care company focused on oxygen therapy and related home-care equipment. Adjacent peer serving the same chronic respiratory patient population through home-care distributors.
• Fisher & Paykel Healthcare: Fisher & Paykel Healthcare is a global respiratory care leader in humidification, CPAP, and neonatal respiratory products. Indirect peer serving hospital and home respiratory patients, often competing for the same pulmonology prescribing decisions.
• Omron Healthcare: Omron Healthcare is a major manufacturer of consumer and clinical nebulizers and respiratory devices with global retail distribution. Competes with PARI in compressor nebulizers and inhaler accessories across pharmacy and consumer channels.
• Vyaire Medical: Vyaire Medical is a large respiratory care company producing nebulizers, ventilators, and pulmonary diagnostics. Directly competes with PARI in both home and clinical nebulization segments globally.
• Invacare (Respiratory segment): Invacare supplies respiratory therapy devices including nebulizers and oxygen concentrators via home medical equipment dealers. Comparable go-to-market model (dealer-driven home respiratory care) overlapping with PARI's pharmacy/Fachhandel channels.

Regional players

• Heyer Medical: Heyer Medical is a German manufacturer of inhalation and anesthesia equipment. Comparable as a German-headquartered specialist in inhalation/nebulization competing for similar hospital and physician customers in Germany and Europe.

Emerging players

• Yuwell: Yuwell is a large Chinese medical device manufacturer producing home-use nebulizers and oxygen equipment. Represents a low-cost competitor in the same compressor-nebulizer category, increasingly active in European pharmacy channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/STApari
• Facebookfacebook.com/PARIGmbH
• LinkedInlinkedin.com/company/parigroup
• Instagraminstagram.com/pari_gmbh

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PARI GmbH